Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Fine

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2021
Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fateTyler M Lu, Sean Houghton, Tarig Magdeldin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Common variation in genes related to innate immunity and risk of adult gliomaPreetha Rajaraman, Alina V Brenner, Mary Ann Butler, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
Plos One|December 14, 2012
Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilizationChibawanye I Ene, Lincoln Edwards, Gregory Riddick, et al.
Cell Reports|March 21, 2019
Modeling Patient-Derived Glioblastoma with Cerebral OrganoidsAmanda Linkous, Demosthenes Balamatsias, Matija Snuderl, et al.
Neuro-Oncology|October 15, 2014
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)Patrick Y Wen, Timothy F Cloughesy, Benjamin M Ellingson, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Cell|January 3, 2008
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cellsJeongwu Lee, Myung Jin Son, Kevin Woolard, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2021
Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fateTyler M Lu, Sean Houghton, Tarig Magdeldin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Common variation in genes related to innate immunity and risk of adult gliomaPreetha Rajaraman, Alina V Brenner, Mary Ann Butler, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
Plos One|December 14, 2012
Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilizationChibawanye I Ene, Lincoln Edwards, Gregory Riddick, et al.
Cell Reports|March 21, 2019
Modeling Patient-Derived Glioblastoma with Cerebral OrganoidsAmanda Linkous, Demosthenes Balamatsias, Matija Snuderl, et al.
Neuro-Oncology|October 15, 2014
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)Patrick Y Wen, Timothy F Cloughesy, Benjamin M Ellingson, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Cell|January 3, 2008
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cellsJeongwu Lee, Myung Jin Son, Kevin Woolard, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
Pageof 17